| Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
| Tel: |
15076683720 |
| Email: |
klq@cw-bio.com |
| Products Intro: |
Product Name:Tubulin inhibitor 33 CAS:2944462-67-1 Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
| Company Name: |
Nantong Hanfang Biotechnology Co. , Ltd.
|
| Tel: |
hanfangpharma@126.com; 18616537568 |
| Email: |
hanfangpharma@126.com |
| Products Intro: |
CAS:2944462-67-1 Purity:98% HPLC Package:10mg;1g;10g;100g;1kg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Tubulin inhibitor 33 CAS:2944462-67-1 Package:1removed
|
Tubulin inhibitor 33 manufacturers
|
| | Tubulin inhibitor 33 Basic information |
| | Tubulin inhibitor 33 Chemical Properties |
| Boiling point | 651.899±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.307±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 10.717±0.40(predicted) |
| | Tubulin inhibitor 33 Usage And Synthesis |
| Uses | Tubulin inhibitor 33, a tubulin polymerization inhibitor, inhibits tubulin polymerization in a dose-dependent manner with an IC50 of 9.05 μM. Tubulin inhibitor 33 has antitumor effects and induces cell apoptosis that can be used for antitumor research[1]. | | in vivo | Tubulin inhibitor 33 (Compound 3a) (5 mg/kg; i.p. everyday for 14 days) significantly inhibits melanoma tumor growth with tumor growth inhibition (TGI) of 62.96%[1].
| Animal Model: | B16-F10 melanoma model in C57 mice[1] | | Dosage: | 5 mg/kg | | Administration: | Intraperitoneal injection (i.p.) | | Result: | Significantly inhibited melanoma tumor growth with a TGI of 62.96%.
|
| | References | [1] Ren Y, et.al. X-ray Crystal Structure-Guided Discovery of Novel Indole Analogues as Colchicine-Binding Site Tubulin Inhibitors with Immune-Potentiating and Antitumor Effects against Melanoma. J Med Chem. 2023 May 25;66(10):6697-6714. DOI:10.1021/acs.jmedchem.3c00011 |
| | Tubulin inhibitor 33 Preparation Products And Raw materials |
|